RIPK3 and pancreatic neoplasm: Despite IMB5036′s ability to partially activate apoptosis and pyroptosis, its primary mode of action is necroptosis, initiated by the upregulation of RIPK1, RIPK3, and largely MLKL in pancreatic cancer cells [168].